PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
AgingPain
Interventions
DRUG

Tramadol extended release 200 mg

Tramadol extended release 200 mg: Administration of a single 200mg tramadol extended-release tablet

BEHAVIORAL

CP/T

Subjects were evaluated for perception and tolerance of electrical current. An experimentally induced pain model utilizing electrical stimulation from the FDA approved Neurometer, as the painful stimulus was used to assess Current Perception Threshold and Pain Tolerance Threshold (CP/T) in young and elderly subjects following administration of tramadol and of placebo.

DRUG

Placebo

Administration of a single placebo tablet identical in appearance to a 200mg tramadol extended-release tablet

Sponsors
All Listed Sponsors
collaborator

Labopharm Inc.

INDUSTRY

collaborator

MDS Pharma Services

INDUSTRY

lead

Université de Montréal

OTHER

NCT02329561 - PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects | Biotech Hunter | Biotech Hunter